Page last updated: 2024-09-04

2-(phenylmethyl)-1-naphthol and 12-hydroxy-5,8,10,14-eicosatetraenoic acid

2-(phenylmethyl)-1-naphthol has been researched along with 12-hydroxy-5,8,10,14-eicosatetraenoic acid in 1 studies

Compound Research Comparison

Studies (2-(phenylmethyl)-1-naphthol)	Trials (2-(phenylmethyl)-1-naphthol)	Recent Studies (post-2010) (2-(phenylmethyl)-1-naphthol)	Studies (12-hydroxy-5,8,10,14-eicosatetraenoic acid)	Trials (12-hydroxy-5,8,10,14-eicosatetraenoic acid)	Recent Studies (post-2010) (12-hydroxy-5,8,10,14-eicosatetraenoic acid)
9	0	0	1,162	18	136

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arenberger, P; Armah, B; Kemény, L; Raap, A; Ruzicka, T	1

Other Studies

1 other study(ies) available for 2-(phenylmethyl)-1-naphthol and 12-hydroxy-5,8,10,14-eicosatetraenoic acid

Article	Year
The lipoxygenase inhibitor 2-phenylmethyl-1-naphthol (DuP 654) is a 12(S)-hydroxyeicosatetraenoic acid receptor antagonist in the human epidermal cell line SCL-II. Skin pharmacology : the official journal of the Skin Pharmacology Society, 1993, Volume: 6, Issue:2 Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Carcinoma, Squamous Cell; Epidermal Cells; Epidermis; Humans; Hydroxyeicosatetraenoic Acids; Naphthols; Receptors, Cell Surface; Receptors, Eicosanoid; Skin Neoplasms; Tumor Cells, Cultured	1993

Article

Year

The lipoxygenase inhibitor 2-phenylmethyl-1-naphthol (DuP 654) is a 12(S)-hydroxyeicosatetraenoic acid receptor antagonist in the human epidermal cell line SCL-II.

Skin pharmacology : the official journal of the Skin Pharmacology Society, 1993, Volume: 6, Issue:2

Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Carcinoma, Squamous Cell; Epidermal Cells; Epidermis; Humans; Hydroxyeicosatetraenoic Acids; Naphthols; Receptors, Cell Surface; Receptors, Eicosanoid; Skin Neoplasms; Tumor Cells, Cultured

1993